OR WAIT null SECS
- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Tecnandina’s Ecuador Facility Receives ANVISA Certification
PTSM: Pharmaceutical Technology Sourcing and Management
The Grünenthal Group’s Tecnandina manufacturing plant in Ecuador has received the country’s first certification from the Regulatory Authority of Brazil.
The Grünenthal Group announced on Oct. 1, 2015 that its Tecnandina manufacturing plant in Ecuador has received certification from the Regulatory Authority of Brazil (ANVISA), making it the first production plant in Ecuador to receive ANVISA certification. The certification will allow the company to export pharmaceutical products to Brazil.
Tecnandina SA belongs to the Grünenthal Group, a research-based, pharmaceutical company headquartered in Aachen, Germany.taht offers contract manufacturing from five independent production plants throughout Europe and Latin America. The company manufactures and exports to 17 countries in Central and South America, Switzerland, and the Andean countries.
Source: Grünenthal Group
Related Content:
